K
Keith W. Singletary
Researcher at University of Illinois at Urbana–Champaign
Publications - 69
Citations - 4851
Keith W. Singletary is an academic researcher from University of Illinois at Urbana–Champaign. The author has contributed to research in topics: DMBA & 7,12-Dimethylbenz[a]anthracene. The author has an hindex of 36, co-authored 63 publications receiving 4666 citations.
Papers
More filters
Journal ArticleDOI
Alcohol and Breast Cancer: Review of Epidemiologic and Experimental Evidence and Potential Mechanisms
TL;DR: Further progress in understanding alcohol's enhancing effect on breast cancer will depend on a better understanding of the interactions between alcohol and other risk factors and on additional insights into the multiple biological mechanisms involved.
Journal ArticleDOI
In Vitro Anticancer Activity of Fruit Extracts from Vaccinium Species
TL;DR: In this paper, fruit extracts of four Vaccinium species (lowbush blueberry, bilberry, cranberry, and lingonberry) were screened for anticarcinogenic compounds by a combination of fractionation and in vitro testing of their ability to induce the Phase II xenobiotic detoxification enzyme quinone reductase (QR) and to inhibit the induction of ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine synthesis, by the tumor promoter phorbol 12-myristate 13-acetate (
Journal ArticleDOI
Optical coherence tomography: feasibility for basic research and image-guided surgery of breast cancer.
TL;DR: The results illustrate the potential of OCT for a wide range of basic research studies and for intra-operative image-guidance to identify foci of tumor cells within surgical margins during the surgical treatment of breast cancer.
Journal ArticleDOI
Inhibition of Akt signaling and enhanced ERK1/2 activity are involved in induction of macroautophagy by triterpenoid B-group soyasaponins in colon cancer cells
TL;DR: New insights are provided into the signaling events that control induction of autophagy by B-group soyasaponins in human colon cancer cells and suggest that soyasalonins warrant further study as potential colon cancer chemopreventive agents.
Journal ArticleDOI
Sulforaphane: a naturally occurring mammary carcinoma mitotic inhibitor, which disrupts tubulin polymerization
TL;DR: Evidence is provided that SUL also acts as a breast cancer anti-proliferative agent and has mammary cancer suppressive actions both in cell culture and in the whole animal.